Search research articles
Contact Us
Filters
Showing results (51-60 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|
June 3, 1999
Increasing market share in an information-intensive world: lessons for healthcare. Part 1: Product differentiation and information leverage
A T Porter, B Nabrit-Stephens, K Steiner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 8, 1999
The cost-effectiveness of mixed beam neutron-photon radiation therapy in the treatment of adenocarcinoma of the prostate
R L Maughan, B Brambs, A T Porter, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|
May 27, 1999
The epidemiology of bony metastases: a comparison of metastatic disease rates of the past 20 years
K B Hart, K Weiss, S Tekyi-Mensah, et al.
Urologic Oncology
|
June 22, 2001
Humoral mechanisms in prostate cancer: A role for FSH
A T. Porter, F A C R O, E Ben-Josef
Anticancer Research
|
May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies
L Li, Z Zhu, B Joshi, et al.
European Urology
|
January 1, 1993
Workshop summary: approaches to radical prostatectomy
U E Studer, P J Walther, A T Porter, et al.
Journal of the National Cancer Institute
|
April 5, 1995
Recent trends in incidence and treatment of prostate cancer among elderly men
R K Severson, J E Montie, A T Porter, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1996
Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study
J D Forman, M Duclos, F Shamsa, et al.
Medical Physics
|
May 1, 1992
Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy
D L Mason, J J Battista, R B Barnett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1992
Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary report
W C Mertens, A T Porter, R H Reid, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|
June 3, 1999
Increasing market share in an information-intensive world: lessons for healthcare. Part 1: Product differentiation and information leverage
A T Porter, B Nabrit-Stephens, K Steiner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 8, 1999
The cost-effectiveness of mixed beam neutron-photon radiation therapy in the treatment of adenocarcinoma of the prostate
R L Maughan, B Brambs, A T Porter, et al.
The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|
May 27, 1999
The epidemiology of bony metastases: a comparison of metastatic disease rates of the past 20 years
K B Hart, K Weiss, S Tekyi-Mensah, et al.
Urologic Oncology
|
June 22, 2001
Humoral mechanisms in prostate cancer: A role for FSH
A T. Porter, F A C R O, E Ben-Josef
Anticancer Research
|
May 5, 1999
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies
L Li, Z Zhu, B Joshi, et al.
European Urology
|
January 1, 1993
Workshop summary: approaches to radical prostatectomy
U E Studer, P J Walther, A T Porter, et al.
Journal of the National Cancer Institute
|
April 5, 1995
Recent trends in incidence and treatment of prostate cancer among elderly men
R K Severson, J E Montie, A T Porter, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1996
Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study
J D Forman, M Duclos, F Shamsa, et al.
Medical Physics
|
May 1, 1992
Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy
D L Mason, J J Battista, R B Barnett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1992
Strontium-89 and low-dose infusion cisplatin for patients with hormone refractory prostate carcinoma metastatic to bone: a preliminary report
W C Mertens, A T Porter, R H Reid, et al.
Page
of 12